Lepercq De Neuflize Asset Management LLC Lava Therapeutics Nv Transaction History
Lepercq De Neuflize Asset Management LLC
- $173 Billion
- Q3 2025
A detailed history of Lepercq De Neuflize Asset Management LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Lepercq De Neuflize Asset Management LLC holds 31,000 shares of LVTX stock, worth $51,460. This represents 0.03% of its overall portfolio holdings.
Number of Shares
31,000
Previous 31,000
-0.0%
Holding current value
$51,460
Previous $40.9 Million
18.18%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding LVTX
# of Institutions
27Shares Held
7.26MCall Options Held
131KPut Options Held
51.8K-
Shay Capital LLC New York, NY2.55MShares$4.23 Million0.44% of portfolio
-
Redmile Group, LLC San Francisco, CA2.07MShares$3.44 Million0.36% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.27 Million2.81% of portfolio
-
Gts Securities LLC New York, NY200KShares$332,0000.01% of portfolio
-
Rangeley Capital, LLC New Canaan, CT165KShares$273,9000.22% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $42.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...